References
- Cohen L. A cell population kinetic model for fractionated radiation therapy. Radiology 1971; 101: 419–27
- Overgaard J, Sand Hansen H, Andersen A P, et al. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx. Final report from the Dahanca 2 study. Int J Radiat Oncol Biol Phys 1989; 16: 1065–8
- Rygård J, Sand Hansen H. Bleomycin as adjuvant in radiation therapy of advanced squamous cell carcinoma in the head and neck. Acta Otolaryngol 1979, Suppl 360: 161–6
- Hansen H S, Rygård J, Andersen A P, et al. Bleomycin, methotrexate and vincristine before irradiation of stage III and IV laryngeal and pharyngeal squamous cell carcinoma (DAHANCA I). Acta Oncol 1987; 26: 13–8
- Peto R, Pike M C, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1–39
- Overgaard J, Hjelm-Hansen M, Vendelbo Johansen L, Andersen A P. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol 1988; 27: 147–52
- Wang C C, Blitzer P H, Suit H D. Twice-a-day radiation therapy for cancer of the head and neck. Cancer 1985; 55: 2100–4
- Peters L J, Ang K K, Thames H D, Jr. Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta Oncol 1988; 27: 185–94